Background {#Sec1}
==========

Delivery and its process {#Sec2}
------------------------

Since 1970 A. D, rate of caesarean section has increased in countries with high income. However, this rate in middle to low income countries increases with a specific rising draft \[[@CR1], [@CR2]\]. This increase is significant in developing countries such as Iran with the caesarean section rate of 48%. This prevalence rate is much more than global rate \[[@CR3]\]. The growth of caesarean section rate increases unpleasant outcomes of delivery and neonatal complications such as respiratory distress syndrome, transient tachypnea of newborn and increased NICU admission \[[@CR4], [@CR5]\]. WHO (World Health Organization) has unnecessary announced the rate of caesarean section higher than 15% \[[@CR4]\]. A few factors have led to the growth of caesarean section such as repeated caesarean, high maternal age in pregnancy, pregnancy with IVF (In vitro fertilization) or IUI (Intra uterine insemination), pregnancy after recurrent abortions, desire of physicians to caesarean section, and this belief that the prolapsed uterus and frequency do not occur after caesarean section \[[@CR6]--[@CR10]\]. Abnormal progress of labor and ineffective contractions of uterus are identified as two common reasons of caesarean section \[[@CR11], [@CR12]\].

According to the WHO, normal birth can be defined as:" spontaneous in onset, low-risk at the start of labor, and remaining so throughout labor and delivery. The infant is spontaneously born in the vertex position between 37 and 42 completed weeks of pregnancy" \[[@CR13]\] There will be different methods for labor induction if the progress of labor is not appropriate, which are used alone or in combination together similar to the strip of membranes and the usage of prostaglandins or oxytocin. These methods accelerate the labor progress and decrease the caesarean section frequency \[[@CR14]\]. Nevertheless, a review study conducted on Cochrane explained that the pregnant women are not satisfied about their labor because of the difficulties of labor \[[@CR15]\]. Most recently, the researchers have been paying attention to remove labor difficulties, and following that, to reduce the caesarean section frequency \[[@CR16], [@CR17]\]. Pregnant women need energy during labor; therefore the amount of required energy for active phase of labor should be 50--100 kcal (Kilo calories) \[[@CR16], [@CR17]\]. The drinking and eating are prohibited for pregnant women during labor in hospitals. It is important to know that it will lead to energy reducing, fatigue, and lack of cooperation in pregnant women, and finally could result in reducing the beneficial effects on mother and infant outcomes \[[@CR12], [@CR18], [@CR19]\]. Scheepers et al. showed that the consumption of carbohydrate during labor can reduce the rate of augmented labor and decrease abnormal progress of labor \[[@CR20]\].

Date and its role in the labor {#Sec3}
------------------------------

Among the studied sugars, is the date palm fruit; which is known as the scientific name of *Phoenix dactylifera* L. Date fruit contains different vitamins (riboflavin, biotin, thiamin, folic acid, and ascorbic acid), higher percentage of sugar and carbohydrates, proteins, fatty acids, salt and minerals such as potassium and magnesium \[[@CR21], [@CR22]\]. Date fruit due to energy production and having enough calories, can be helpful for pregnant women during labor, and it can also prevent physical weakness \[[@CR23]--[@CR25]\]. Furthermore, because it contains sugar, it is fast in digestion and absorption \[[@CR25]\]. In addition to generating energy, date fruit also contains necessary and unnecessary fatty acids that can produce prostaglandins playing an important role in cervix ripening, acceleration of delivery progress, increase of uterine contractions, and inducing labor \[[@CR26], [@CR27]\]. In addition, date fruit contains any hormones that prepare uterine to stretching and child birth \[[@CR28]\]. Also, date can accelerate labor process, increase cervix dilatation, and reduce the need for induction \[[@CR23], [@CR24]\]. Moreover, date in Traditional Persian Medicine (TPM) has been mentioned as a facilitator medicinal food for labor \[[@CR29]\]. TPM is an ancient medical system and one of the important complementary and alternative medicines that has been utilized in Iran, India, and the middle east from ancient eras up to now \[[@CR30], [@CR31]\]. Nevertheless, there are few studies supporting the relationship between labor and date.

Most recently, a systematic review conducted on the effects of date fruit on pregnancy and delivery has been published \[[@CR32]\]; however, there are some differences between its reviewed outcomes and this study. Therefore in that study the reporting bias and publication bias have not been regarded in inclusion of studies to meta-analysis. Accordingly this reason can cause wrong changes in meta-analysis results.

Due to the studies conducted on the benefits of date palm fruit on labor process improvement, date can be considered as a factor for increasing vaginal delivery and reducing the frequency of caesarean section in order to prevent its great complications. This systematic review aimed to review clinical studies that investigate the effects of date palm fruit on labor outcomes (duration of labor stages, bishop score, and frequency of cesarean section) compared to routine cares.

Methods {#Sec4}
=======

This systematic review and meta-analysis was reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. This systematic review was not registered on PROSPERO.

Eligibility criteria {#Sec5}
--------------------

### Inclusion and exclusion criteria of studies {#Sec6}

All clinical trials including randomized and quasi-randomized, evaluating the effects of date palm fruit on labor and delivery that have been published from 2000 until August 2019 in English and Persian languages were included in this systematic review. Also, non-randomized clinical trials, editorials, reviews, books, case reports, case series, letter to editors, qualitative studies, and short communications were excluded. There was no limitation for the length of follow-up or treatment.

Inclusion criteria (PICOS format) {#Sec7}
---------------------------------

Participants: all pregnant women in 36--42 weeks of pregnancy with no restrictions on patient's age, nationality, and the number of parity without any serious complication.Interventions: consumption of date (fruit or extract) without restriction in the number of the fruit and the duration of intervention.Controls: The routine cares of pregnant women.Outcomes: The primary outcomes were the duration of labor stages and the secondary outcomes were the frequency of caesarian section and bishop score.Study type: Randomized and quasi-randomized clinical trials.

Search strategy {#Sec8}
---------------

This systematic review was performed in 2019 and the last search was conducted in August 2019. Data have been collected from the databases such as PubMed, Scopus, Web of Knowledge, Clinical Keys, Embase, Google Scholar Search Engine, Scientific Information Database (SID), and IRCT (Iranian Registry of Clinical Trials) to search the relevant articles published from January 2000 to August 2019 using the keywords *Phoenix dactylifera*, date palm, date fruit, labor, and delivery. Also, manual search of the reliable journal data-bases was accomplished, and the references in all review articles were checked for additional related articles. To search for unpublished articles (grey literature), European Association for Grey Literature Exploitation (EAGLE) and Health Care Management Information Consortium (HMIC) were investigated. The search strategy for PubMed is available in Appendix 1 (see Additional file [1](#MOESM1){ref-type="media"}). Investigated data was transferred to Endnote software.

Study selection {#Sec9}
---------------

The selected studies extracted from the databases by Endnote software, were independently evaluated by two authors (AE and RBN). Disagreements between them were referred to the third inspector (MM). At first, the titles of all papers were reviewed and inconsistent studies with the objectives of the study were excluded from the study. In the next step, abstract of chosen studies were reviewed and incompatible studies were excluded. Then, full texts of chosen studies were extracted. In the last stage, full-text articles were surveyed to exclude those that did not match with the inclusion criteria and the study aims. The authors elicited data from all eligible studies and registered the elicited data in the appropriate forms. Data for the primary objective of the review was gathered from the full text of each paper consisting of the trial name, year of publication, study design, sample size, participants, intervention protocol, used parts of plant, comparisons, results, and other characteristics.

Assessment of risk of Bias {#Sec10}
--------------------------

The methodological quality of the included studies and their risk of bias were independently evaluated by two reviewers (MM, ABK) using RevMan 5.3.0 software, in terms of the risk of bias assessment of the Cochrane handbook. The assessment criteria consisted of seven items as follows: Selection bias (allocation concealment); Selection bias (random sequence generation); Performance bias (blinding of participants and personnel); Detection bias (blinding of outcome assessors); Attrition bias (dropouts and exclusion addressing and intention to treat analysis); Reporting bias (selective or nonselective reporting); Other bias (registration of protocol, conflict of interest declaration, ethical criteria, inclusion and exclusion criteria, sample size calculating, and funding sources declaration). Each study was evaluated as High, Low, or Unclear risk of bias for each item. Any disagreements between the two reviewers were resolved by discussion with the corresponding author. Because the number of included studies in meta-analysis was lower than 10 studies, the graphical or statistical methods were not used to evaluate publication bias.

Statistical analysis {#Sec11}
--------------------

The results of the studies were analyzed using "Review Manager" software (RevMan 5.3.0 provided by Cochrane Collaboration). The types of intervention in included studies were similar. We integrated the studies according to the types of outcomes (labor phases duration, frequency of caesarian section, and bishop score). We included all the intended outcomes of the different reports of each trial to the meta-analyses once. Dichotomous data were summarized as risk ratio (RR), and continuous data as mean difference (MD). Heterogeneity between the studies was evaluated using X^2^ (chi-squared) test and I^2^ statistic. I^2^ was used to assess heterogeneity between studies with ≥75%, 25--75, and \< 25% which were considered as high, moderate, and low heterogeneity, respectively, to indicate a substantial heterogeneity. 95% CI was calculated, and due to the small number of included studies and low power of chi-square test for heterogeneity (in terms of the Cochrane handbook for systematic reviews of interventions), *p* \< 0.1 was regarded as significant. Based on the results, sensitivity analysis and subgroup analysis will be performed if needed.

Results {#Sec12}
=======

General characteristics {#Sec13}
-----------------------

We gathered 1531 studies from databases and other hand search sources. Eight of 1531 studies (Eight full-text papers under six trials) had eligibility criteria and were included in qualitative and quantitative analysis \[[@CR33]--[@CR40]\]. Three of them had the same ethic code (910732) (approval code of research ethics committee) and were different reports of one trial \[[@CR33]--[@CR35]\]. Also two other studies were similar and were different reports of one trial \[[@CR36], [@CR37]\]. We included all different outcomes (which considered in our systematic review) of the different reports of each trial to the meta-analysis (if the trial had multiple reports). The flowchart of searching and inclusion process of studies is shown in Fig. [1](#Fig1){ref-type="fig"}(According to PRISMA statement). Fore of included studies had used the date palm fruit \[[@CR33], [@CR36], [@CR39], [@CR40]\], and one study had used date fruit honey \[[@CR38]\]. Descriptions and characteristics of the reviewed studies are shown in Table [1](#Tab1){ref-type="table"}. No side effects were reported for date palm in any of the studies. The minimum and maximum intervention durations of founded studies were two days and four weeks, respectively. Date palm and its extracts were orally utilized in all of the studies. Sample sizes of these studies were 89 to 210 participants. 653 participants were included in the analysis, 325 participants in intervention group, and 328 in control group. Ages of participants were ranged from 20 to 40. All of these studies had control groups consisting of placebo and routine cares in one study \[[@CR38]\], and routine cares in other studies \[[@CR33], [@CR36], [@CR39], [@CR40]\]. However, placebo control group was not included in meta-analysis and qualitative analysis. Fig. 1Flowchart of selection strategy and method (PRISMA statement)Table 1Characteristics of included studies (PICOS)NumberAuthor/\
YearStudy designParticipants and\
Sample sizeInterventionControlDuration of interventionOutcomes\
(considered in this study)Results1Ahmed et al., 2018 \[[@CR39]\]Randomized, controlled, clinical trial57 pregnant women26 intervention group31 control group7 date's fruits on the permissionRoutine caresOnce(1--3) Duration of first, second and third stage of labor1. ↓ Duration of the first and the third stage of labor in intervention groups significantly compared with control group2. ↑ Duration of the second stage of labor in intervention groups but not significantly compare with control group2Razali et al.,2017 \[[@CR40]\]Randomized controlled clinical trial154 nulliparous singleton pregnant women77 intervention group77 control group7 date's fruits(approximately80 g)Routine cares1--4 weeks(1--3) Duration of first, second and third stage of labor(4) Frequency of caesarian section1. ↓ Duration of the first and the third stage of labor in intervention groups but not significantly compare with control group2. ↑ Duration of the second stage of labor in intervention groups but not significantly compare with control group3. No significant difference between two groups in mode of delivery3Kariman and Jadidi et al., 2015 \[[@CR36], [@CR37]\]Randomized, controlled, clinical trial110 nuliparous pregnant women55 intervention group55 control group7 date's fruit per dayRoutine caresFrom week 38 of pregnancy to onset of delivery signs(1) Duration of active phase of labor(2) Bishop score(3) Frequency of caesarian section1. Significant ↓ of active phase of labor in intervention group compared with control group2. Significant ↓in bishop score after intervention compared with control group3. No significant differences in mode of delivery between two group4. ↑ Bishop score significantly after intervention compared with control group5. ↑ Cervical dilatation significantly after intervention compared with control group6. ↑ Cervical effacement significantly after intervention compared with control group7. ↑ Spontaneous labor significantly after intervention compared with control group4Kordi et al.,2013,2014, 2017 \[[@CR33]--[@CR35]\]Quasi-randomized, controlled, clinical trial210 pregnant women with gestational age of 37--38 weeks105 intervention group105 control group70--75 g date's fruit per dayRoutine cares1--3 weeks(1) Bishop score(2) Frequency of caesarian section(3--5) Duration of first, second and third stage of labor1. Significant ↑ of the mean Bishop Score in intervention group compared with control group2. No significant difference between two groups in mode of delivery (↓ frequency of cesarean section in intervention group)1. The average length of the second phase and the third phase in the intervention group was significantly lower than the control group2. Spontaneous start of labor in the intervention group was significantly more than the control group3. No significant difference between average length of active phase of labor in the two4. ↑Cervical dilatation in intervention group compared with control group (significant)5. ↓Length of pregnancy in intervention group compared with control group (significant)5Kordi et al.,2010 \[[@CR38]\]Randomized double blinded controlled clinical trial60 nuliparous pregnant women with gestational age of 37--42 weeks30 intervention group30 control group132 g date's honey syrup from 4 cm cervix dilatation to laborRoutine caresMaximum 1 day(1) Duration of active phase of labor(2) Duration of second stage of laborSignificant ↓in duration of active and second phases of labor

Risk of bias within studies (Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}) {#Sec14}
---------------------------------------------------------------------------------------------

The details of risk of bias within included studies and authors judgment are listed in Table [2](#Tab2){ref-type="table"}. Fig. 2Risk of bias graphFig. 3Risk of bias summaryTable 2Risk of bias within studiesBiasAuthors judgmentSupport for judgment**Ahmed et al. (2018)** \[[@CR39]\] Random sequence generationLow riskSimple random sampling has been used Allocation concealmentUnclear riskNo specific information Blinding of participants and personnelHigh riskOpen label manner Blinding of outcome assessorsHigh riskOpen label manner Incomplete outcome dataHigh riskIntention to treat analysis has not conducted. Selective reportingLow riskProtocol is unavailable but the authors have reported their expected mentioned outcomes OtherHigh riskNo registered protocol, sample size calculating method is not specified**Razali et al. (2017)** \[[@CR40]\] Random sequence generationLow riskSealed envelope numbers has been used Allocation concealmentLow riskIt was done using "sealed envelope" manner Blinding of participants and personnelHigh riskOpen label manner Blinding of outcome assessorsHigh riskOpen label manner Incomplete outcome dataLow riskThe dropped out has been mentioned and intention to treat has been analyzed Selective reportingLow riskProtocol is unavailable but the both primary and secondary outcomes have been reported OtherLow riskRegistered protocol exist, sample size calculating method is specified, Ethical approval exist, Specified inclusion and exclusion criteria, specified funding source, no conflict of interest**Kariman and Jadidi et al. (2015)** \[[@CR36], [@CR37]\] Random sequence generationLow riskRandom number generator has been used Allocation concealmentUnclear riskNo specific information Blinding of participants and personnelHigh riskOpen label manner Blinding of outcome assessorsHigh riskOpen label manner Incomplete outcome dataLow riskThe dropped out has been mentioned and intention to treat has been analyzed Selective reportingHigh riskProtocol is available but secondary outcomes have not been reported OtherLow riskRegistered protocol exist, sample size calculating method is specified, Ethical approval exist, Specified inclusion and exclusion criteria, specified funding source, no conflict of interest**Kordi et al.(2013, 2014, 2017)** \[[@CR33]--[@CR35]\] Random sequence generationHigh riskThe days of the Week have been used for randomization Allocation concealmentUnclear riskNo specific information Blinding of participants and personnelHigh riskOpen label manner Blinding of outcome assessorsHigh riskOpen label manner Incomplete outcome dataLow riskThe dropped out has been mentioned and intention to treat has been analyzed Selective reportingLow riskProtocol is available and both primary and secondary outcomes have been reported OtherLow riskRegistered protocol exist, sample size calculating method is specified, Ethical approval exist, Specified inclusion and exclusion criteria, specified funding source, no conflict of interest**Kordi et al. (2010)** \[[@CR38]\] Random sequence generationLow riskSimple random sampling has been used Allocation concealmentHigh riskThere was no evidence for allocation concealment Blinding of participants and personnelHigh riskOpen label manner Blinding of outcome assessorsHigh riskOpen label manner Incomplete outcome dataLow riskThere was no lost to follow up Selective reportingLow riskProtocol is unavailable but both primary and secondary outcomes have been reported OtherHigh riskConflict of interest didn't declared, no specified inclusion and exclusion criteria

### Random sequence generation {#FPar1}

Four studies of 5 studies had used random number table, random generator or computer programmed random sequencing; and thus, they were rated as low risk of bias. Another study used no reliable randomization method and was evaluated as high risk of bias.

### Allocation concealment {#FPar2}

One study of included studies had used sealed-envelopes method to the allocation concealment and was evaluated as low risk of bias. Three trials of five included trials did not determine the method of allocation concealment, and were evaluated as unclear risk of bias. One trial had not concealment and was evaluated as high risk of bias.

### Blinding of participants and personnel {#FPar3}

Due to the consumption of date fruit as intervention and routine care as control, all of the included studies had not performed blinding and were rated as high risk of bias.

### Blinding of outcome assessment {#FPar4}

All of these studies were assessed as high risk of bias; because they had no evidence of blinding of outcome assessors.

### Incomplete outcome data {#FPar5}

Out of 5 trials, 2 trials have mentioned the dropped out and analyzed the intention to treat, and 2 trials had no dropped out or lost to follow up; therefore they were rated as low risk of bias. Also, one study had attrition for missing participants; however, the statistical analysis was not followed by the intention to treat.

### Selective reporting {#FPar6}

One study had registered protocol; but the reported outcomes did not match with registered outcomes and were given the high risk of bias. Other included studies had reported their expected outcomes and were assessed as low risk of bias.

### Other bias {#FPar7}

Three trials had registered protocol, specified funding source, appropriate ethical criteria, inclusion and exclusion criteria, specified sample size calculating method, and declaration of conflict of interest; therefore, they were rated as low risk of bias. Other trials did not have some of mentioned cases and were rated as high risk of bias.

Outcomes {#Sec15}
--------

We considered common outcome among the included studies in quantitative integration, included active phase of labor duration, first stage of labor duration, second stage of labor duration, and third stage of labor duration as primary outcomes; and bishop score and frequency of caesarian section as secondary outcomes. Also, we performed the sensitivity analysis, because one trial of included trials was quasi-randomized study. Sensitivity analysis did not change the results of primary meta-analysis. The summary of sensitivity analysis is shown in Table [3](#Tab3){ref-type="table"}. The forest plots of sensitivity analyses are available in Appendix 2--6 (See Additional file [2](#MOESM2){ref-type="media"}). Moreover, we performed subgroup analysis for two subgroups (Intervention during labor, and intervention during pregnancy). The results of subgroup analysis showed significant changes in the third stage of labor meta-analysis results. The forest plots of subgroup analyses are available in Appendix 7--10 (See Additional file [3](#MOESM3){ref-type="media"}). Table 3The summary of sensitivity analysesNumberMeasured outcomeMeta-analyses of all studies\
(Overall effect statistical significance)Sensitivity Analyses^a^\
(Overall effect statistical significance)1Second stage of laborP = 0.44P = 0.642Third stage of laborP = 0.82P = 0.393Active phase of labor**P = 0.01**^**b**^**P = 0.01**^**b**^4Bishop score**P \< 0.00001**^**b**^**P \< 0.00001**^**b**^5Frequency of cesarean sectionP = 0.23P = 0.59^a^quasi-randomized study (Kordi 2013, 2014, 2017) \[[@CR33]--[@CR35]\] removed from meta-analysis^b^the significant values are shown with bold font

### Active phase of labor {#FPar8}

Three trials with 380 participants were included (190 in intervention group and 190 in control group). There was moderate heterogeneity among the studies (I^2^ = 89%, *P* = 0.0002). The quantitative synthesis showed that date consumption significantly reduce the duration of active phase of labor compared with control group (MD = − 109.3, 95%CI (− 196.32, − 22.29), *P* = 0.01) (Fig. [4](#Fig4){ref-type="fig"}). Fig. 4Forest plot of the duration of active phase of labor

### First stage of labor {#FPar9}

Two studies reported the duration of first stage of labor. Totally, 211 participants were included (103 in intervention group and 108 in control group). Moderate heterogeneity accompanied (I^2^ = 71%, *P* = 0.06). There was no significant difference between two groups (MD = − 76.16, 95%CI (− 198.51, 46.18), *P* = 0.22) (Fig. [5](#Fig5){ref-type="fig"}). Fig. 5Forest plot of the duration of first stage of labor

### Second stage of labor {#FPar10}

We collected data from 4 trials with 481 participants (238 in intervention group and 243 in control group). The heterogeneity was high (I^2^ = 93%, *P* \< 0.00001). There was no significant difference between two groups (MD = − 6.41, 95%CI \[− 22.67, 9.86\], *P* = 0.44) (Fig. [6](#Fig6){ref-type="fig"}). Fig. 6Forest plot of the duration of second stage of labor

### Third stage of labor {#FPar11}

Three trials with 421 participants (208 in intervention group and 213 in control group) described the duration of the third stage of labor. The intervention cannot decrease the duration of the third stage of labor (MD = 0.39, 95%CI (− 2.92, 3.71), *P* = 0.82). The heterogeneity was high (I^2^ = 89%, *P* = 0.0001) (Fig. [7](#Fig7){ref-type="fig"}). The subgroup analysis showed that the intervention during pregnancy significantly reduces the duration of the third stage of labor compared with control group. (Appendix 9) (See Additional file [3](#MOESM3){ref-type="media"}). Fig. 7Forest plot of the duration of third stage of labor

### Bishop score {#FPar12}

Two trials reported data on the bishop score with 320 participants (160 in intervention group and 160 in control group). There was no heterogeneity (I^2^ = 0%, *P* = 0.60). The intervention significantly improved the bishop score, compared to control group (MD = 2.45, 95%CI (1.87, 3.04), *P* \< 0.00001) (Fig. [8](#Fig8){ref-type="fig"}). Fig. 8Forest plot of the bishop score

### Frequency of caesarian section {#FPar13}

Three trials had showed the effect of intervention on frequency of caesarian section. 474 participants were included in this outcome meta-analysis (237 in intervention group and 237 in control group). Low heterogeneity was accompanied (I^2^ = 0%, *P* = 0.38). There was no significant difference between two groups. (Risk Ratio = 0.80, 95%CI (0.56, 1.15), *P* = 0.23) (Fig. [9](#Fig9){ref-type="fig"}). Fig. 9Forest plot of the caesarian section frequency

### Adverse effects {#FPar14}

No side effects have been reported in any of the included studies.

Discussion {#Sec16}
==========

Based on the performed searches, this is the first systematic review conducted on the effects of date on bishop score and frequency of caesarean section, and second one on the effects of date on the duration of labor stages. Meta-analysis showed that the consumption of date fruit can significantly reduce the duration of the active phase and improve the bishop score, and may reduce the frequency of cesarean section in intervention group compared to control group. Based on meta-analysis, date palm fruit consumption resulted in a significant reduction in the duration of active phase of labor compared with control group; however, it is not observed in the first, second, and the third stage of labor.

Nasiri et al. in their systematic review have achieved different results about the duration of labor stages. Those results are not reliable, because they had included three duplicated published studies in their meta-analysis. In that study, bishop score and frequency of caesarean section were not investigated \[[@CR32]\].

Different mechanisms have been expressed on the effects of date palm on the labor process. Date palm fruit has high calorie, and is proposed as an energizer. The sugar in date fruit is glucose with simple digestion and absorption. Date fruit provides and maintains required energy for pregnant woman to prevent tiredness. It leads to normal progress of labor, due to providing continual glucose and preserving body electrolytes \[[@CR23], [@CR25]\]. Oxytocin and prostaglandins have been widely utilized for ripening of cervix, stimulation of uterine contractions, and induction and stimulation of labor especially when the duration of latent phase of labor has been expanded \[[@CR41], [@CR42]\]. Misuse of oxytocin and prostaglandins and insufficient maternal care in labor, can lead to delivery complications \[[@CR43], [@CR44]\]. Myometer oxytocin receptors are increasing in the last weeks of pregnancy. Estrogen and progesterone levels change in the 34--35 weeks of pregnancy that these changes could lead to the improvement of irritability of uterine, improvement of responsiveness of uterine to contractor factors, and the improvement of cervical preparation to labor \[[@CR45]\]. Therefore, date fruit consumption in last weeks of pregnancy can cause labor induction and stimulation, because date fruit acts on prostaglandin receptors, causes early stimulation of uterine contractions, and improves response to syntocinon if it is necessary \[[@CR41]\]. Fatty acids in date palm in addition to production and reservation of energy play important role in the prostaglandins production, and following that, in the reinforcement of uterine muscles \[[@CR26], [@CR27], [@CR46]\]. On the other hand, drinking water after consuming date fruit during labor is effective on labor progress and shortens the second and the third stages of labor \[[@CR47]\]. As well as date palm can increase antioxidant capacity for 4 h, and following that increases pain tolerance, this results in reduction of the first and the third stages of labor \[[@CR22], [@CR26]\]. Also, date fruit has anti-inflammatory and antioxidant properties and it is rich in calcium, serotonin, and tannin, and can play a role in contraction of smooth muscles of uterine \[[@CR22], [@CR48]\]. As mentioned earlier, consumption of date fruit had significantly increased the bishop score and cervical dilatation. Bishop score (that contains cervical dilatation and ...) is known as evaluation criteria of labor progress and the increasing factor of normal vaginal labor \[[@CR49], [@CR50]\]. Lack of preparation of cervix and induction of labor can lead to increase of caesarean section rate and postpartum hemorrhage \[[@CR51]--[@CR53]\]. However, increase of the bishop score and preparation of cervix, can increase normal vaginal labor rate and reduce the caesarean section rate \[[@CR54]\]. The low dose of oxytocin causes the improvement of the bishop score and the preparation of cervix \[[@CR55]\], thus the consumption of date fruit affects the improvement of the bishop score by increasing the activity of myometer contraction. This is a confirmation of possible hypothesis of oxytocin in date fruit and its effect on uterine muscle contraction \[[@CR22], [@CR24], [@CR56]\]. Also, date fruit contains saturated and unsaturated fatty acids linoleic, oleic, and stearic. Linoleic acid breaks down to the arachidonate, and then to the eicosanoid. The eicosanoids finally convert to the prostaglandins and they improve the preparation of cervix by increasing subserosal fluid and making changes in collagen bands, and they cause the increasing of sensitivity of uterine to oxytocin \[[@CR36], [@CR48], [@CR57]\].

Generally, the mechanism of cervical preparation is unknown; however, changes in levels of estrogen and progesterone, increasing of the prostaglandins production, increasing of myometer sensitivity to oxytocin and prostaglandins, and their interactions are identified to be effective \[[@CR45], [@CR54]\].

Up to the best of our knowledge, the most common causes of cesarean section are abnormal progress of labor and non-effective contractions of uterine \[[@CR11], [@CR12], [@CR16]\]. Lack of eating energizer foods during labor lead to the increasing of non-effective contractions of uterine and following that increasing of the augmented delivery and increasing the cesarean section rate \[[@CR20]\]. Limited reserves of glycogen and body fluids in pregnant women that have limited consumption of food and liquids during labor can cause low perfusion and low nutrition of uterine, which can be followed by abnormal labor progress, prolonged labor, and the increasing rate of cesarean section \[[@CR36]\].

Limitations {#Sec17}
-----------

One of the limitations of this study was the lack of specified standard for the kind and the amount of date fruit that must be consumed to bring positive effects on labor progression and cervix preparation. Also, it was not determined that, how long at what intervals of consumption of date fruit is needed to energy supply during labor, reduce the cesarean section rate and promotion of labor outcomes.

Another limitation of this study was the high risk of bias in performed studies. Especially, due to the methods of studies and using the date palm fruit in the studies, blinding of participants and researchers was not possible. Therefore, for this reason, performance bias was raised in included studies. Furthermore, none of these studies had outcome assessor blinding.

The other limitation of this study was the unknown time of intervention and duration of intervention in the most studies.

Conclusion {#Sec18}
==========

Despite widespread utilizing of date palm, there is not enough clinical evidence to support the clinical effects, which were mentioned in review articles and traditional medical systems. Based on this study result, date fruit can reduce the duration of active phase and improve the bishop score. The growing trend of recent studies about date palm provides scientific rationale for date palm clinical abilities; however, due to from the low to mediate quality of the studies, it seems that the other studies are needed to prove these results better than this.
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